Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Li, C;Bonazzoli, E;Bellone, S;Choi, J;Dong, WL;Menderes, G;Altwerger, G;Han, C;Manzano, A;Bianchi, A;Pettinella, F;Manara, P;Lopez, S;Yadav, G;Riccio, F;Zammataro, L;Zeybek, B;Yang-Hartwich, Y;Buza, N;Hui, P;Wong, S;Ravaggi, A;Bignotti, E;Romani, C;Todeschini, P;Zanotti, L;Zizioli, V;Odicino, F;Pecorelli, S;Ardighieri, L;Silasi, DA;Litkouhi, B;Ratner, E;Azodi, M;Huang, GS;Schwartz, PE;Lifton, RP;Schlessinger, J;Santin, AD

2019-01-01